Alliant gets $16M VA endoscope contract; Polish med tech HTL Strefa preps for IPO;

@FierceMedDev: Sequenom appoints new CEO amid diversification. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: CMS proposal to restrict coverage of artificial limbs facing pushback from amputees. Story | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: Clorox reveals smartphone-powered UV cleaning device for drug-resistant bacteria. Article | Follow @EmilyWFierce

> Alliant Healthcare Products has gained a $16 million, 5-year contract with the Department of Veterans Affairs to provide endoscopes. More

> The private equity owners of Unilab--Apax Partner and Nordic Capital--are said to be in talks to sell the diagnostics company. Story

> Transcend Medical was found by a federal judge to not have infringed on Glaukos ($GKOS) patents relating to a glaucoma treatment. Brief

> Polish medical device company HTL Strefa will launch an IPO on the Warsaw bourse by the end of October to raise up to $53.4 million. Article

Biotech News

@FierceBiotech: Why would Martin Shkreli hike an old drug price by 5000%? Only a 'moron' would ask. More | Follow @FierceBiotech

@JohnCFierce: The British papers seem particularly outraged by Shkreli. Feeling a bit sorry/outraged for the Yanks? Understandable. | Follow @JohnCFierce

@DamianFierce: "Industry analysts often cite the day Taiwanese animators got involved as the peak of the biotech bubble." Watch | Follow @DamianFierce

> Henri Termeer backs biotech upstart Artax's autoimmune research. Story

> AstraZeneca embraces crowdsourcing in a mix-and-match cancer R&D contest. Article

> Deerfield leads a $75M round for Akari. More

Pharma News

@FiercePharma: China's WuXi NextCODE builds on Fudan University partnership with Children's Hospital pact. FiercePharmaAsia story | Follow @FiercePharma

@EricPFierce: Novo to build a $78M insulin pen plant in Iran. FiercePharmaManufacturing news | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: New ulcerative colitis data could help Pfizer's Xeljanz pick up the pace. Article | Follow @CarlyHFierce

> Valeant's latest tax-cutting tactic, courtesy of Luxembourg. Report

> J&J faces Tylenol lobbying allegations in first case to go to trial over med. Story

> Rough waters for pharma's U.S. pricing power, yes. Sea change? Nope. Article

Drug Delivery News

> Drug-carrying nanoparticles disguised as platelets could help heal blood vessels. Report

> BDSI touts fed's plan to remove barriers on medication-assisted treatment of drug addiction. More

> West Pharma adds medication adherence tracking capability to its drug delivery system. Item

> Silicone vaginal ring could deliver HIV, herpes drugs at low cost. Story

> Impel NeuroPharma bags $4M to develop its device to deliver drugs across blood-brain barrier. Article

Pharma Manufacturing News

> Huge Russian plasma products plant moving forward. Article

> Novo to build $78M plant in Iran. News

> China's ShangPharma to build biologics plant in Qidong. Story

> GSK sets up network to help its suppliers cut emissions. Item

> McKesson nails down another international supply chain deal. Report

Pharma Asia News

> Serum Institute pushes for dengue cure fast track, Times of India says. Article

> WuXi NextCODE bolsters Fudan University alliance with Children's Hospital pact. News

> Novartis CEO says company to make heart failure drug Entresto at Singapore plant. Item

> Shanghai-based ZAI Lab in-licenses autoimmune candidate from UCB. Story

> China's BGI and Huawei partner on Big Data genomic system storage. More

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.